Alisol A is potentially therapeutic in human breast cancer cells

  • Authors:
    • Yanyan Shi
    • Mopei Wang
    • Pan Wang
    • Ting Zhang
    • Jingyi Yu
    • Lunyong Shi
    • Mo Li
    • Hao Wang
    • Qingying Zhang
    • Hongmei Zhao
  • View Affiliations

  • Published online on: June 22, 2020     https://doi.org/10.3892/or.2020.7654
  • Pages: 1266-1274
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Recent developments in breast cancer therapy have significantly improved patient survival rate; however, recurrence remains a major problem. Systemic treatment of breast cancer with available therapies is not curative. Natural products can be potentially used for treating cancer. Recently, a wide range of pharmacological activities has been reported for Alismatis Rhizoma, a popular traditional Chinese medicine. However, the mechanisms via which its compounds act on breast cancer remain unclear. The present study aimed to investigate the potential of natural therapeutic agents from Alismatis Rhizoma for treating breast cancer. Human breast cancer MDA‑MB‑231 cells were treated with four main protostane triterpenes from Alismatis Rhizoma, including alisol A, alisol A 24‑acetate, alisol B and alisol B 23‑acetate. Among these, alisol A significantly inhibited cell viability. Alisol A induced cell apoptosis, G1 phase cell cycle arrest, autophagy, and intracellular reactive oxygen species (ROS) generation in MDA‑MB‑231 cells. The number of APE1‑/γH2AX‑/LC3‑II positive cells was also significantly higher compared with that of negative control cells. All these results were dose‑dependent. Cleaved caspase‑3, cleaved caspase 9, Bcl‑2, and p‑p38 expression indicated cell apoptosis after alisol A treatment. The changes in cyclin A and cyclin D1 expression was associated with cell cycle arrest upon alisol A treatment. Furthermore, LC3‑II expression upon alisol A treatment was indicative of autophagy. Alisol A treatment can induce autophagy‑dependent apoptosis in human breast cancer cells via induction of ROS and DNA damage. Thus, Alisol A might serve as a new therapeutic agent against breast cancer.
View Figures
View References

Related Articles

Journal Cover

September-2020
Volume 44 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shi Y, Wang M, Wang P, Zhang T, Yu J, Shi L, Li M, Wang H, Zhang Q, Zhao H, Zhao H, et al: Alisol A is potentially therapeutic in human breast cancer cells. Oncol Rep 44: 1266-1274, 2020.
APA
Shi, Y., Wang, M., Wang, P., Zhang, T., Yu, J., Shi, L. ... Zhao, H. (2020). Alisol A is potentially therapeutic in human breast cancer cells. Oncology Reports, 44, 1266-1274. https://doi.org/10.3892/or.2020.7654
MLA
Shi, Y., Wang, M., Wang, P., Zhang, T., Yu, J., Shi, L., Li, M., Wang, H., Zhang, Q., Zhao, H."Alisol A is potentially therapeutic in human breast cancer cells". Oncology Reports 44.3 (2020): 1266-1274.
Chicago
Shi, Y., Wang, M., Wang, P., Zhang, T., Yu, J., Shi, L., Li, M., Wang, H., Zhang, Q., Zhao, H."Alisol A is potentially therapeutic in human breast cancer cells". Oncology Reports 44, no. 3 (2020): 1266-1274. https://doi.org/10.3892/or.2020.7654